News in the Pharmacological Treatment of Female Urinary Incontinence
Authors:
A. Martan
Authors‘ workplace:
Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha
Published in:
Čas. Lék. čes. 2006; 145: 549-553
Category:
Review Article
Overview
The article addresses the issue of pharmacological treatment of female urinary incontinence. It summarizes the two types of incontinence, i.e. stress urinary incontinence (SUI) and urgency incontinence, or even just urgency symptoms (overactive bladder – OAB). It focuses on the role of urethra in maintaining continence for women. The article covers new possibilities of pharmacological treatment of SUI with detailed analysis of the effects of a new drug - duloxetine (YENTREVE). In the second part, the article outlines the drugs most frequently used in the treatment of urgency incontinence or just urgency symptoms, mentioning new preparations and new forms of preparations already in use. It analyzes the effects of tolterodine (DETRUSITOL), oxybutinine (UROXAL) and solifenacine (VESICARE).
Key words:
female urinary incontinence, pharmacological treatment.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Autosomal Recessive Ethnical Diseases of Czech Roma
- Paediatric and Adolescence Gynaecology in Czech Republic
- Hippocampus, Structure of the Brain and Schizophrenia
- Trends in the Clinical Biochemistry and Laboratory Diagnostics